Keyphrases
Gene Expression
100%
Endothelial Cells
100%
Endothelial Nitric Oxide Synthase (eNOS)
100%
Tumor Necrosis Factor-α
100%
Advanced Glycation End Products
100%
Gene Synthesis
100%
MRNA Expression
45%
Protein Expression
27%
Cord
27%
Human Umbilical Vein
27%
Old Age
9%
Incubation
9%
Aging
9%
Diabetes
9%
Type 1 Diabetes Mellitus (T1DM)
9%
Vascular Complications
9%
Lipopolysaccharide
9%
Interferon-α (IFN-α)
9%
Interleukin-1β
9%
Kidney Failure
9%
Product-specific
9%
Human Serum Albumin
9%
β2-microglobulin (β2-MG)
9%
Vascular Remodeling
9%
Specific Compounds
9%
Vascular Dysfunction
9%
Cultured Endothelial Cells
9%
Vasculopathy
9%
Uremia
9%
Product Effect
9%
Medicine and Dentistry
Gene Expression
100%
Endothelial Cell
100%
Tumor Necrosis Factor
100%
Endothelial Nitric Oxide Synthase
100%
Advanced Glycation End-Product
100%
Messenger RNA
45%
Umbilical Vein
27%
Secretion (Process)
18%
Protein Expression
18%
Diabetes Mellitus
9%
Diabetes
9%
Incubation
9%
Renal Failure
9%
Interferon
9%
Lipopolysaccharide
9%
Vascular Disease
9%
Uremia
9%
Human Serum Albumin
9%
Vascular Remodeling
9%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
Gene Synthesis
100%
Tumor Necrosis Factor
100%
Advanced Glycation End-Product
100%
Nitric Oxide Synthase
100%
Messenger RNA
45%
Protein Expression
18%
Secretion (Process)
18%
Microglobulin
9%
Human Serum Albumin
9%
Interferon
9%
Lipopolysaccharide
9%
Immunology and Microbiology
Gene Expression
100%
Tumor Necrosis Factor
100%
Glycation
100%
Gene Synthesis
100%
Nitric Oxide Synthase
100%
Umbilical Vein
27%
Secretion (Process)
18%
Protein Expression
18%
interferon
9%
Serum (Blood)
9%
Albumin
9%
Neuroscience
Gene Expression
100%
Necrosis
100%
Advanced Glycation End Product
100%
Endothelial Nitric Oxide Synthase
100%
Messenger RNA
45%
Umbilical Vein
27%
Protein Expression
18%
Diabetes Mellitus
9%
Lipopolysaccharide
9%
Interferon
9%
Vascular Disease
9%
Human Serum Albumin
9%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelial Nitric Oxide Synthase
100%
Tumor Necrosis Factor
100%
Advanced Glycation End Product
100%
Messenger RNA
45%
Diabetes Mellitus
9%
Kidney Failure
9%
Lipopolysaccharide
9%
Interferon
9%
Vascular Disease
9%
Uremia
9%
Human Serum Albumin
9%
Vascular Remodeling
9%